Skip to Content
Search Menu

Mapping the Spatial Landscape of Ovarian Cancer

Shimrit Mayer, Postdoctoral Research Associate at the CRUK Cambridge Institute, presents a spatial proteomic atlas across ovarian cancer histology subtypes and explores how differences in immune activation and spatial organisation between primary tumours and metastases may contribute to immune escape and inform future patient stratification.
Shimrit Mayer

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Related

Ricardo Coelho

Tumor-Associated Macrophages and TNF-α May Help Rescue Treatment Efficacy in Ovarian Cancer

/ Ricardo Coelho
Ovariecancer Play the Video 4:03
Gini Fleming

ASCO 2026: Telisotuzumab Adizutecan Shows Promising Activity in Platinum-Resistant Ovarian Cancer

/ Gini Fleming
ASCO26Ovariecancer Play the Video 3:15
Clare Turnbull

ESMO Breast 2026: BRCA Direct Pathways and the UK Retrospective Genetic Testing Program

/ Clare Turnbull
Breast cancerOvariecancer Play the Video 15:39
Tanjina Kader

New Spatial Profiling Method Reveals Immune Interactions During Ovarian Cancer Evolution

/ Tanjina Kader
Ovariecancer Play the Video 13:20
Martin Højgaard

ASCO 2026: Selective PARP1 Inhibitor Shows Encouraging Early Results

/ Martin Højgaard
ASCO26Breast cancerOvariecancer Play the Video 11:37

Testing New Therapies for Ovarian Cancer in a 3D Model

/ Christiane Helgestad Gjerde / Katrin Kleinmanns / Emmet McCormack / Line Bjørge
Ovariecancer
Back to top